Overview
Bayer (Monsanto) has paid over $11 billion in total to resolve Roundup/glyphosate claims (per public reports). In March 2026 the court preliminarily approved a $7.25 billion settlement covering current and future cancer claims; the opt-out deadline for class members was June 4, 2026 (per AP reporting). At the September 14, 2026 fairness hearing before Judge Timothy Boyer of the Circuit Court for the City of St. Louis, objectors attacked the deal’s structure — calling it the “first future settlement to ever lock in people” with a 20-year claims period — while proponents noted that only 24 trials have been completed a decade after the first lawsuits and that an estimated 40,000 to 50,000 cases remain (per The New Lede). The judge did not rule on the record and gave the parties until the end of the week to submit proposed orders (per The New Lede). In September 2026 the U.S. Supreme Court held that federal law preempts some state failure-to-warn claims against Bayer (per Reuters). As of early October 2026 no ruling had been issued, and Bayer had asked for a delay in the decision (per public reports). Registration and claim submission remain closed pending final approval (per the official settlement website). IARC classifies glyphosate as “probably carcinogenic to humans” (Group 2A, per IARC).
Key people
Companies involved
Settlement amounts
Bayer has paid over $11 billion in total (per public reports), including a $7.25 billion settlement covering current and future claims (per court, Mar 2026). The settlement covers non-Hodgkin lymphoma claims only, with tiered compensation by exposure, age and NHL type: per the settlement terms as discussed at the Sep 14, 2026 fairness hearing, an occupational user diagnosed with an aggressive NHL under age 60 could see a payout of $165,000 on average, with individual awards varying from 80% to 120% (per The New Lede). Final approval is still pending as of the Oct 21 2026 check: the official settlement site (updated Sep 21 2026) says registration and claim submission are unavailable until the court grants final approval, and Bayer had asked for a delay in the decision (per public reports, Oct 2026). No outcome can be promised.
Key dates
- October 21, 2026As of the Oct 21 2026 check: no final-approval order on the public record; the official settlement site (updated Sep 21 2026) says registration and claim submission are unavailable until the court grants final approval
- September 14, 2026Fairness hearing held in St. Louis Circuit Court; the judge did not rule on the record and gave the parties until the end of the week to submit proposed orders (per The New Lede and Reuters)
- September 11, 2026U.S. Supreme Court: federal law preempts some state failure-to-warn claims against Bayer and other pesticide makers (per Reuters)
- June 4, 2026Opt-out deadline for settlement class members (per AP reporting)
- March 1, 2026Preliminary approval of the $7.25 billion settlement covering current and future claims (per court order and reports)
- August 10, 2018First $469 million cancer verdict (per court records; later reduced on appeal)
- April 15, 2015IARC classifies glyphosate as “probably carcinogenic to humans” (Group 2A) (per IARC)
Updates
- Updated Oct 2, 2026Roundup: SCOTUS preemption ruling (Sep 2026) affects the docket; the $7.25B settlement fairness ruling is still pending — Bayer asked for a delay in the decision (per Reuters and public reports, Oct 2026).
- Updated Sep 14, 2026Fairness hearing held Sep 14, 2026 (St. Louis Circuit Court); objections raised by opposing plaintiffs’ counsel; ruling not yet issued; registration stays closed pending final approval (per The New Lede and the official settlement website).
- Updated Aug 6, 2026Seeded from research (Aug 2026): $7.25B settlement preliminarily approved Mar 2026; fairness hearing rescheduled to Sep 14, 2026 (per the official settlement website).
Notable filings
No notable filings recorded yet. Docket entries are added from public court records as they appear.
FAQ
What is the Roundup lawsuit about?
Claimants alleged that use of Roundup (glyphosate) contributed to cancer — most often non-Hodgkin lymphoma (per complaints). The consolidated litigation was In re Roundup Insecticide Products Liability Litigation, MDL 1417, N.D. Cal. (per JPML).
How much has Bayer paid in total?
Bayer (Monsanto) has paid over $11 billion in total to resolve Roundup/glyphosate claims, including individual verdicts and settlements (per public reports).
What is the $7.25 billion settlement?
In March 2026 the court preliminarily approved a $7.25 billion settlement covering current and future claims; final approval was still pending as of August 2026, with the fairness hearing set for September 14, 2026, and registration not yet open (per the official settlement website, August 6, 2026).
Can I still file a Roundup claim?
Plaintiff firms continue to review new cancer claims for the future claims pool (per firm pages, August 2026). Whether you qualify depends on your facts — this is not legal advice.
What did IARC conclude about glyphosate?
IARC classifies glyphosate as “probably carcinogenic to humans” (Group 2A, per IARC). Other agencies have reached different conclusions; this page reports each source’s position without taking a side.
How much will I receive?
Per-claim amounts vary under the claims program; no outcome can be promised. Reported per-claim figures are case-specific and are not verified against the docket.
Think this matters to you?
This page is neutral reference material — not legal advice. If you were affected, the next step is a free case review with a licensed attorney working this matter.
Start free case review →